This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Personal history of certain other diseases
Z21_PERSONAL_HISTORY_CERTA_OTH_DISEA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
737 |
4. Check minimum number of eventsNone |
737 |
5. Include endpointsNone |
737 |
6. Filter based on genotype QC (FinnGen only) |
737 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[8-9]
Similar endpoints
↥List of similar endpoints to
Personal history of certain other diseases
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 737 | 603 | 134 |
| Unadjusted period prevalence (%) | 0.18 | 0.21 | 0.06 |
| Median age at first event (years) | 31.02 | 28.30 | 43.26 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 661
- Matched controls
- 6608
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
8718.1
323.0
400
*
Z86.7
ICD-10 Finland
Personal history of diseases of the circulatory system
+∞
122.8
114
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
42.3
83.5
104
29
N05AH04
ATC
quetiapine; oral
5.1
67.7
267
776
W84
ICPC
Pregnancy high risk
7.5
60.8
157
263
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
10.0
56.8
120
144
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
5.0
56.5
216
587
T36
ICD-10 Finland
Poisoning by systemic antibiotics
8.6
55.3
128
179
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
33.2
50.4
66
22
N05BA04
ATC
oxazepam; oral
3.9
48.6
258
937
Z86.5
ICD-10 Finland
Personal history of other mental and behavioural disorders
+∞
48.5
46
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
8.3
44.4
104
146
Z72.2
ICD-10 Finland
Drug use
25.2
44.0
62
27
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.2
43.1
196
609
SPAT1272
SPAT
Drug screening
53.9
42.3
50
10
SPAT1301
SPAT
No procedures
3.3
42.0
302
1352
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
9.7
41.7
88
103
P19
ICPC
Drug abuse
18.4
41.6
65
39
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
42.3
41.3
51
13
F10.20
ICD-10 Finland
Alcohol dependence currently independent
24.3
40.8
58
26
N05AH03
ATC
olanzapine; systemic
6.1
40.6
119
229
Z86.0
ICD-10 Finland
Personal history of other neoplasms
+∞
38.9
37
*
SPAT1249
SPAT
Treatment-related counselling outside office
2.9
38.3
398
2241
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
7.9
36.9
88
126
N07BB01
ATC
disulfiram; oral
9.4
36.2
77
91
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.8
36.1
132
325
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
8.8
36.0
80
102
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.7
35.3
185
634
SPAT1263
SPAT
Sampling
2.8
34.1
384
2209
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.6
33.9
178
608
O80.8
ICD-10 Finland
Other single spontaneous delivery
4.4
33.7
134
358
N06AB04
ATC
citalopram; systemic
3.4
33.2
196
735
B01AA03
ATC
warfarin; systemic
5.4
32.8
105
222
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
6.0
32.7
96
183
N06AX11
ATC
mirtazapine; oral
2.9
32.5
260
1199
N05BA01
ATC
diazepam; systemic, rectal
4.4
31.5
127
342
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
32.6
30.7
40
13
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.4
29.8
82
143
N05AX08
ATC
risperidone; systemic
5.0
29.5
102
234
N06AB06
ATC
sertraline; oral
3.6
29.1
149
494
Z00.0
ICD-10 Finland
General medical examination
3.1
28.9
187
736
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
2.7
28.7
281
1438
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
21.3
28.6
42
21
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.9
28.5
212
917
SPAT1310
SPAT
Counselling related to known health issue
2.6
28.5
294
1549
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
41.0
28.3
35
9
N03AE01
ATC
clonazepam; systemic
6.3
28.2
78
137
SPAT1307
SPAT
Psychosocial counselling and guidance
3.5
27.8
151
522
SPAT1254
SPAT
Administration of medicine
3.3
27.6
158
567
N06AX16
ATC
venlafaxine; oral
3.3
27.5
164
608
SPAT1260
SPAT
Consultation of another employee
3.2
27.4
173
666
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
+∞
27.3
26
*
SPAT1240
SPAT
Therapeutic discussion
3.1
26.8
180
722
N03AG01
ATC
valproic acid; systemic, rectal
5.2
26.8
88
190
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
21.7
26.8
39
19
B01AB05
ATC
enoxaparin; parenteral
2.9
25.2
181
757
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.7
24.8
118
365
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
28.8
24.7
33
12
N06AB03
ATC
fluoxetine; oral
3.5
24.6
129
431
P29
ICPC
Psychological sympt/compl other
3.9
24.3
108
314
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
58.3
24.2
28
5
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
23.8
24.1
34
15
Z86.1
ICD-10 Finland
Personal history of infectious and parasitic diseases
+∞
24.1
23
*
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
2.3
24.1
340
2056
SPAT1379
SPAT
Health check-up of pregnant person
2.5
24.0
261
1381
SPAT1216
SPAT
Assessment of functional ability
4.0
23.8
102
287
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
13.6
23.7
41
32
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.4
23.5
294
1668
N05AX12
ATC
aripiprazole; systemic
4.7
23.3
83
195
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
25.8
23.3
32
13
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
56.2
23.2
27
5
N05CF01
ATC
zopiclone; oral
2.7
23.2
193
875
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
22.8
309
1812
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
22.8
219
1076
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
21.6
22.8
33
16
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
7.4
22.7
55
80
N05BA12
ATC
alprazolam; oral
4.1
22.6
94
257
F10.24
ICD-10 Finland
Alcohol depence active use
16.5
22.6
36
23
AA1AD
NOMESCO Finland
CT of head and brain
3.2
22.0
131
478
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
7.4
21.9
53
77
L03
ICPC
Low back symptom/complaint
2.5
21.8
206
1001
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.0
21.7
93
261
T74.1
ICD-10 Finland
Physical abuse
7.2
21.5
53
79
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.6
21.5
106
335
N06AB10
ATC
escitalopram; oral
2.5
21.5
216
1084
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
9.7
21.1
43
47
P01
ICPC
Feeling anxious/nervous/tense
2.6
21.0
181
830
Z86.3
ICD-10 Finland
Personal history of endocrine, nutritional and metabolic diseases
+∞
20.9
20
*
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.8
20.8
150
620
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
31.2
20.7
27
9
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
43.1
20.6
25
6
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.6
20.4
100
314
RS121
NOMESCO Finland
NA
18.0
20.2
31
18
N02AX02
ATC
tramadol; systemic, rectal
2.4
20.1
228
1207
SPAT1312
SPAT
General health counselling
2.2
20.0
313
1926
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
25.5
19.7
27
11
F10.09
ICD-10 Finland
Alcohol intoxication UNS
8.2
19.6
44
57
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.7
19.6
156
681
N03AX16
ATC
pregabalin; oral
2.8
19.6
142
586
P18
ICPC
Medication abuse
16.2
19.4
31
20
N05AA02
ATC
levomepromazine; systemic
6.2
19.3
53
92
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.2
19.3
77
202
O98.4
ICD-10 Finland
Viral hepatitis complicating pregnancy, childbirth and the puerperium
35.5
19.0
24
7
Z86.2
ICD-10 Finland
Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
+∞
18.8
18
*
Z22.5
ICD-10 Finland
Carrier of viral hepatitis
72.0
18.8
21
*
M54.5
ICD-10 Finland
Low back pain
2.2
18.8
244
1371
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
2.7
18.7
143
607
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
2.4
18.7
187
921
P15
ICPC
Chronic alcohol abuse
8.1
18.6
42
55
SPAT1211
SPAT
Application of soft bandage
3.5
18.5
91
286
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
7.4
18.4
44
63
W78
ICPC
Pregnancy
2.1
18.4
292
1788
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.6
18.4
150
663
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
45.4
18.3
22
5
C07AA05
ATC
propranolol; systemic
2.4
18.3
179
872
WX110
NOMESCO Finland
Local anesthesy
2.3
18.3
515
4022
-1
NOMESCO Finland
NA
2.1
18.3
314
1987
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.2
18.1
71
183
Z32.1
ICD-10 Finland
Pregnancy confirmed
2.4
18.1
184
914
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.0
18.1
115
435
Z2446
NOMESCO Finland
Social worker
3.7
18.0
83
247
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.6
17.8
144
631
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
8.1
17.8
40
52
SPAT1380
SPAT
Postpartum check-up
2.3
17.8
212
1134
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
2.2
17.5
242
1386
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.8
17.5
77
221
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
7.8
17.4
40
54
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
24.8
17.4
24
10
Z72.1
ICD-10 Finland
Alcohol use
14.4
17.4
29
21
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.2
17.3
67
171
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.7
16.9
130
553
A03
ICPC
Fever
2.3
16.8
191
997
WX307
NOMESCO Finland
Obstetric epidural analgesia
2.4
16.8
170
840
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
+∞
16.7
16
*
SPAT1197
SPAT
Extensive health check-up of expecting family
2.1
16.7
259
1552
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
92.4
16.6
18
*
HMAK
NOMESCO Finland
NA
2.6
16.6
134
584
M79.6
ICD-10 Finland
Pain in limb
2.1
16.6
238
1380
A46
ICD-10 Finland
Erysipelas
3.9
16.4
70
195
N05AF03
ATC
chlorprothixene; systemic
7.0
16.3
40
60
N02BE01
ATC
paracetamol; systemic, rectal
2.3
16.3
538
4363
Z71.8
ICD-10 Finland
Other specified counselling
2.1
16.2
222
1259
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
16.2
174
882
N05BA02
ATC
chlordiazepoxide; systemic
11.2
16.1
30
28
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
25.2
16.1
22
9
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
15.0
15.9
26
18
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.8
15.9
112
450
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
5.3
15.8
49
99
M54.9
ICD-10 Finland
Dorsalgia, unspecified
3.0
15.8
99
370
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
15.8
75
229
N03AX09
ATC
lamotrigine; oral
3.5
15.8
76
235
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
27.0
15.7
21
8
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
22.7
15.6
22
10
C03CA01
ATC
furosemide; systemic
3.1
15.4
91
326
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.8
15.3
51
112
F61.0
ICD-10 Finland
Mixed personality disorders
6.9
15.3
38
58
SPAT1283
SPAT
Restricted health certificate
2.0
15.2
248
1501
Z72.0
ICD-10 Finland
Tobacco use
6.4
15.2
40
66
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.9
15.1
34
45
P01AB01
ATC
metronidazole; oral, rectal
2.0
15.1
267
1673
J01DB01
ATC
cefalexin; oral
2.2
15.0
548
4530
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
11.7
14.9
27
24
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
14.9
116
495
N03AX12
ATC
gabapentin; oral
2.9
14.8
97
372
SPAT1153
SPAT
Removal of sutures
2.2
14.8
171
891
SPAT1196
SPAT
Monitoring of normal pregnancy
2.5
14.8
133
613
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
8.7
14.6
31
37
F39
ICD-10 Finland
Unspecified mood [affective] disorder
5.7
14.6
42
78
F11.21
ICD-10 Finland
Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment
36.9
14.5
18
5
Z72.8
ICD-10 Finland
Other problems related to lifestyle
15.8
14.5
23
15
K02.1
ICD-10 Finland
Caries of dentine
1.9
14.4
445
3403
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
14.3
379
2734
SPAT1265
SPAT
Breathalyser
13.8
14.3
24
18
SPAT1227
SPAT
Substance abuse rehabilitation
13.8
14.3
24
18
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
14.1
134
634
RS222
NOMESCO Finland
NA
11.8
13.9
25
22
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.3
13.8
143
708
N06BA04
ATC
methylphenidate; oral
4.1
13.7
53
136
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
2.2
13.6
164
869
Z86.6
ICD-10 Finland
Personal history of diseases of the nervous system and sense organs
+∞
13.6
13
*
Z3231
NOMESCO Finland
Registered nurse
2.1
13.5
177
971
Z3232
NOMESCO Finland
Midwife
2.2
13.5
149
758
O99.80
ICD-10 Finland
The fear of childbirth
2.8
13.4
93
369
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.7
13.4
60
175
R06.0
ICD-10 Finland
Dyspnoea
2.3
13.4
142
706
N07BA03
ATC
varenicline; oral
3.9
13.4
55
149
SPAT1200
SPAT
Guidance for breast-feeding and breast care
3.3
13.3
70
232
P76
ICPC
Depressive disorder
2.8
13.3
91
358
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
3.2
13.3
74
254
R05
ICPC
Cough
2.1
13.2
177
977
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
6.2
13.2
35
59
N05CD07
ATC
temazepam; oral
3.7
13.2
59
172
O80.0
ICD-10 Finland
Spontaneous vertex delivery
1.9
13.1
285
1896
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.0
13.1
32
48
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.1
13.0
51
132
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
29.0
13.0
17
6
EBA00
NOMESCO Finland
Extraction of tooth
1.9
12.9
266
1734
N05CF02
ATC
zolpidem; oral
2.4
12.9
119
552
O23.5
ICD-10 Finland
Infections of the genital tract in pregnancy
6.0
12.9
35
61
F92.0
ICD-10 Finland
Depressive conduct disorder
10.8
12.8
24
23
R50.9
ICD-10 Finland
Fever, unspecified
2.5
12.7
106
467
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
12.6
310
2143
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
12.6
359
2608
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.0
12.5
76
277
RS211
NOMESCO Finland
NA
13.5
12.5
21
16
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
12.5
518
4278
W01
ICPC
Question of pregnancy
5.4
12.4
37
72
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
12.4
90
367
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
12.4
101
439
SPAT1357
SPAT
Monitoring of problem during pregnancy
3.4
12.3
60
188
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
2.3
12.2
129
642
N06AB05
ATC
paroxetine; oral
3.6
12.2
55
162
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
12.1
57
173
Z39.2
ICD-10 Finland
Routine postpartum follow-up
1.9
12.1
230
1450
B17.1
ICD-10 Finland
Acute hepatitis C
21.8
12.1
17
8
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.8
12.0
51
142
S06.0
ICD-10 Finland
Concussion
2.7
12.0
88
360
SXA20
NOMESCO Finland
Local application of medicine to mouth
2.8
12.0
82
323
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
12.0
216
1334
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
47.6
11.9
14
*
N06AX21
ATC
duloxetine; oral
2.7
11.9
84
337
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
12.0
11.9
21
18
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
11.8
239
1533
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.9
11.8
73
270
A02BC02
ATC
pantoprazole; systemic
1.8
11.8
329
2354
SPAT1360
SPAT
Extensive global examination
3.4
11.8
58
183
F31.8
ICD-10 Finland
Other bipolar affective disorders
5.3
11.7
35
69
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.2
11.6
44
111
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
11.6
83
336
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
10.3
11.6
22
22
SPAT1252
SPAT
Overall medication plan or its review
4.3
11.5
42
102
SPAT1251
SPAT
Organisation of medication
5.4
11.5
34
66
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
+∞
11.5
11
*
LCH11
NOMESCO Finland
Pharmacologic abortion
2.7
11.5
84
343
P16
ICPC
Acute alcohol abuse
8.1
11.4
25
32
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
11.4
106
493
R11
ICD-10 Finland
Nausea and vomiting
2.9
11.4
73
275
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
11.3
116
565
S18
ICPC
Laceration/cut
1.9
11.3
218
1376
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.5
11.2
39
91
SPAT1243
SPAT
Psychiatric/psychological examination
3.4
11.1
54
169
R07.3
ICD-10 Finland
Other chest pain
3.4
11.1
54
169
R60.0
ICD-10 Finland
Localized oedema
3.2
11.0
59
198
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
7.6
11.0
25
34
N05BA06
ATC
lorazepam; systemic, sublingual
4.9
11.0
35
74
J01FF01
ATC
clindamycin; systemic
2.0
11.0
168
972
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
10.9
134
708
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.6
10.9
49
144
P99
ICPC
Psychological disorders other
4.0
10.9
43
113
F10.25
ICD-10 Finland
Alcohol dependence continuous use
8.5
10.9
23
28
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
4.1
10.8
41
104
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
18.2
10.8
16
9
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.8
10.8
35
76
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
7.7
10.7
24
32
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
21.9
10.7
15
7
N05AD01
ATC
haloperidol; systemic
6.5
10.7
27
43
Z91.5
ICD-10 Finland
Personal history of self-harm
61.0
10.7
12
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
10.6
114
567
K04.0
ICD-10 Finland
Pulpitis
2.4
10.6
98
454
Z29
ICPC
Social problem NOS
4.4
10.5
37
87
N05AB03
ATC
perphenazine; systemic, rectal
4.7
10.5
35
78
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
10.5
61
217
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.0
10.5
60
211
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
10.4
129
685
D72
ICPC
Viral hepatitis
33.1
10.4
13
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.2
10.4
55
184
N05BE01
ATC
buspirone; oral
5.2
10.3
31
62
C07AB07
ATC
bisoprolol; oral
2.0
10.3
161
935
WX290
NOMESCO Finland
Other blockade of nerve
1.7
10.2
376
2873
N04AA02
ATC
biperiden; systemic
7.1
10.2
24
35
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
10.2
260
1785
N76.0
ICD-10 Finland
Acute vaginitis
2.3
10.1
95
444
WX730
NOMESCO Finland
Conventional respirator
10.3
10.1
19
19
A02BC01
ATC
omeprazole; systemic
2.0
10.0
152
872
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
10.0
34
78
SGA01
NOMESCO Finland
Tooth opening as first aid
2.0
9.9
131
711
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
12.4
9.9
17
14
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
20.4
9.8
14
7
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
10.8
9.8
18
17
N02AA05
ATC
oxycodone; systemic
3.0
9.8
57
203
WZC30
NOMESCO Finland
Teaching
2.8
9.8
64
244
L01
ICPC
Neck symptom/complaint
2.2
9.8
104
515
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
5.7
9.7
27
49
ZY000
NOMESCO Finland
Hospital inpatient
6.0
9.7
26
45
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
9.7
44
131
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.2
9.7
51
170
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
55.8
9.7
11
*
K04.08
ICD-10 Finland
Other specified pulpit
2.6
9.6
70
283
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.9
9.6
161
956
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
10.2
9.6
18
18
SPAT1308
SPAT
Sexual health counselling
1.7
9.5
230
1545
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
9.5
87
402
MAC40
NOMESCO Finland
Pharmacological induction or advancement of labor
3.5
9.5
43
128
SPAT1192
SPAT
Gynaecological examination
1.9
9.5
157
930
P74
ICPC
Anxiety disorder/anxiety state
2.8
9.4
62
237
P06
ICPC
Sleep disturbance
2.5
9.4
78
342
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
12.6
9.4
16
13
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.5
9.4
43
129
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
9.4
110
569
F51.0
ICD-10 Finland
Nonorganic insomnia
2.1
9.4
116
614
X58
ICD-10 Finland
Exposure to other specified factors
2.2
9.3
97
476
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.8
9.3
217
1441
K08.3
ICD-10 Finland
Retained dental root
3.6
9.1
40
116
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
15.8
9.1
14
9
E66.01
ICD-10 Finland
Obesity due to excess calories
2.5
9.1
71
303
K05.31
ICD-10 Finland
Periodontitis pronounced
3.4
9.0
42
128
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.4
9.0
26
50
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
6.2
9.0
23
38
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
18.9
9.0
13
7
J01MA12
ATC
levofloxacin; systemic
2.3
9.0
83
385
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.2
9.0
46
151
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.2
9.0
94
460
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
8.9
115
618
WX002
NOMESCO Finland
Sedation and analgesia
2.2
8.9
94
461
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.4
8.9
42
129
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.6
8.9
64
260
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
9.7
8.8
17
18
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
3.7
8.8
37
104
R51.80
ICD-10 Finland
Headache
2.0
8.7
126
707
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
50.7
8.7
10
*
N06AX03
ATC
mianserin; oral
4.3
8.7
31
75
B01AB04
ATC
dalteparin; parenteral
4.2
8.7
32
80
A41.9
ICD-10 Finland
Sepsis, unspecified
5.9
8.7
23
40
ZYY01
NOMESCO Finland
Contact between professionals
16.5
8.6
13
8
ZXY49
NOMESCO Finland
Other health care provider
9.1
8.6
17
19
N06AX12
ATC
bupropion; oral
2.4
8.6
75
337
RD211
NOMESCO Finland
NA
4.0
8.6
33
86
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.9
8.5
50
180
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
8.5
75
339
J01CA08
ATC
pivmecillinam; oral
1.6
8.5
301
2235
N06AA09
ATC
amitriptyline; systemic
3.0
8.5
49
174
SPAT1262
SPAT
Handing over of treatment supplies
2.3
8.5
82
387
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
2.7
8.5
58
230
W79
ICPC
Unwanted pregnancy
3.2
8.4
43
141
A06AD11
ATC
lactulose; oral
2.5
8.4
64
269
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
8.3
8
*
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.5
8.3
66
283
N30.0
ICD-10 Finland
Acute cystitis
2.0
8.3
106
565
SAA02
NOMESCO Finland
Basic examination of mouth
1.7
8.3
491
4164
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
3.7
8.3
35
99
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
8.3
232
1613
Z00.8
ICD-10 Finland
Other general examinations
2.5
8.3
63
265
WX892
NOMESCO Finland
Monitored bed care
3.2
8.2
42
138
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
8.2
52
197
ZXD05
NOMESCO Finland
Urgent procedure
1.7
8.2
214
1458
N05AN01
ATC
lithium; oral
4.1
8.2
30
75
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.0
8.1
46
160
SPAT1247
SPAT
Outpatient detoxication and monitoring
17.4
8.1
12
7
H02AB06
ATC
prednisolone; systemic
1.7
8.1
239
1683
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
2.7
8.1
52
199
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
10.2
8.1
15
15
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.1
8.1
42
140
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
8.0
180
1171
ZY010
NOMESCO Finland
Hospital outpatient
2.6
8.0
59
244
N06AA12
ATC
doxepin; systemic
3.9
7.9
31
82
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.8
7.9
50
188
R42
ICD-10 Finland
Dizziness and giddiness
2.0
7.9
105
571
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
7.8
386
3094
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
7.8
129
759
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.5
7.7
35
105
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
15.2
7.7
12
8
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.7
7.7
173
1123
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
7.6
7.7
17
23
N05AH02
ATC
clozapine; systemic
4.8
7.7
24
51
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.8
7.7
31
85
F15.0
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication
18.6
7.6
11
6
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
12.0
7.6
13
11
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
25.3
7.6
10
*
F31
ICD-10 Finland
Bipolar affective disorder
5.9
7.6
20
35
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
7.5
112
635
Z12
ICPC
Relationship problem with partner
3.5
7.5
33
97
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
7.5
212
1470
R53
ICD-10 Finland
Malaise and fatigue
1.8
7.5
136
824
U02
ICPC
Urinary frequency/urgency
2.0
7.5
93
493
S02
ICPC
Pruritus
3.2
7.5
38
125
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.1
7.4
39
131
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
4.0
7.4
28
72
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.7
7.4
48
184
RS221
NOMESCO Finland
NA
5.4
7.4
21
40
IFC01
NOMESCO Finland
Withdrawal and replacement therapy for opioid addiction
80.9
7.4
8
*
127
Kela drug reimbursment
Transplant complication
80.9
7.4
8
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.7
7.4
49
191
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.9
7.4
43
154
Y09
ICD-10 Finland
Assault by unspecified means
13.5
7.4
12
9
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
4.6
7.3
24
54
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.6
7.3
24
54
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
+∞
7.3
7
*
R21
ICPC
Throat symptom/complaint
1.6
7.3
219
1541
S80.0
ICD-10 Finland
Contusion of knee
2.4
7.3
59
255
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
3.2
7.3
37
122
N06AX26
ATC
vortioxetine; oral
2.5
7.3
54
225
EBA30
NOMESCO Finland
Excision of root of tooth
3.9
7.2
28
74
Z01.2
ICD-10 Finland
Dental examination
1.6
7.2
301
2297
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.0
7.2
39
134
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
7.4
7.2
16
22
Z30.0
ICD-10 Finland
General counselling and advice on contraception
2.0
7.2
93
500
D11
ICPC
Diarrhoea
1.9
7.2
104
583
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
2.8
7.1
45
168
T40.6
ICD-10 Finland
Poisoning: Other and unspecified narcotics
20.3
7.1
10
5
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
7.1
58
250
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
3.2
7.1
36
118
SPAT1255
SPAT
Intravenous administration of medicine
3.2
7.1
36
118
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
6.1
7.1
18
30
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.1
7.1
18
30
K10.3
ICD-10 Finland
Alveolitis of jaws
2.6
7.1
49
195
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.9
7.1
41
147
B86
ICD-10 Finland
Scabies
4.2
7.1
25
61
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4.1
7.0
26
66
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
5.0
7.0
21
43
SPAT1281
SPAT
Other administrative function
2.3
7.0
65
300
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
2.0
7.0
85
444
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.1
7.0
77
388
N03AF01
ATC
carbamazepine; oral, rectal
3.7
7.0
29
82
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
14.0
6.9
11
8
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
4.9
6.9
21
44
P03
ICPC
Feeling depressed
1.9
6.9
108
623
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.7
6.9
28
78
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
8.4
6.8
14
17
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
6.8
62
286
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
11.1
6.8
12
11
F13.21
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment
40.5
6.8
8
*
S15
ICPC
Foreign body in skin
3.0
6.8
36
123
N93.8
ICD-10 Finland
Other specified abnormal uterine and vaginal bleeding
4.8
6.8
21
45
RS311
NOMESCO Finland
NA
16.9
6.8
10
6
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
16.9
6.8
10
6
SPAT1229
SPAT
Assessment of need for aid
3.2
6.8
33
106
N03AX11
ATC
topiramate; oral
3.4
6.8
31
95
A01
ICPC
Pain general/multiple sites
2.5
6.8
53
226
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
3.0
6.7
38
132
SPAT1104
SPAT
Monitoring of emergency patient
2.8
6.7
40
147
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.2
6.7
33
107
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
5.3
6.7
19
37
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
6.7
214
1525
ZX120
NOMESCO Finland
Intravenous
2.6
6.6
47
191
R55
ICD-10 Finland
Syncope and collapse
2.5
6.6
52
221
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
12.4
6.6
11
9
R74
ICPC
Upper respiratory infection acute
1.5
6.6
268
2020
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
8.8
6.6
13
15
-67
ICPC
Referral to physician/hospital
6.9
6.5
15
22
SPAT1202
SPAT
Intra-articular injection
6.9
6.5
15
22
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
6.5
62
291
Z73.9
ICD-10 Finland
Problem related to life-management difficulty, unspecified
6.3
6.5
16
26
F12.20
ICD-10 Finland
Dependence caused by cannabis currently independent
70.5
6.4
7
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.4
6.4
29
88
O04.6
ICD-10 Finland
Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage
4.5
6.4
21
48
JN4BD
NOMESCO Finland
Extensive body CT
2.8
6.4
39
146
F41.00
ICD-10 Finland
Moderate panic disorder
3.6
6.4
27
78
Z08
ICPC
Social welfare problem
6.6
6.4
15
23
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
6.6
6.4
15
23
SPAT1189
SPAT
Other ultrasound examination during pregnancy
2.2
6.4
66
324
SGC00
NOMESCO Finland
Local medication of root channels of tooth
2.0
6.4
79
419
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.3
6.4
13
16
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.7
6.4
149
974
F40.1
ICD-10 Finland
Social phobias
2.9
6.3
37
134
IGV01
NOMESCO Finland
Psychiatric network contact
4.7
6.3
20
44
P72
ICPC
Schizophrenia
4.7
6.3
20
44
TQW11
NOMESCO Finland
Vacuum treatment of wound
9.4
6.3
12
13
Z51.2
ICD-10 Finland
Other chemotherapy
9.4
6.3
12
13
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
6.3
53
235
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
6.3
80
428
P17
ICPC
Tobacco abuse
4.9
6.3
19
40
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
6.3
6
*
N07BC51
ATC
buprenorphine, combinations; sublingual
+∞
6.3
6
*
339
Kela drug reimbursment
Product containing buprenorfine and naloxone
+∞
6.3
6
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
+∞
6.3
6
*
O35.4
ICD-10 Finland
Maternal care for (suspected) damage to fetus from alcohol
26.9
6.2
8
*
F60.2
ICD-10 Finland
Dissocial personality disorder
26.9
6.2
8
*
SPAT1270
SPAT
Narcotic/sobriety test
26.9
6.2
8
*
SPAT1280
SPAT
Provision of administrative assistance
26.9
6.2
8
*
O26.82
ICD-10 Finland
Exhaustion and fatigue pregnancy-related
2.8
6.2
37
136
D10
ICPC
Vomiting
2.0
6.2
74
386
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.8
6.2
38
143
X78
ICD-10 Finland
Intentional self-harm by sharp object
6.4
6.2
15
24
C03DA01
ATC
spironolactone; oral
2.9
6.2
35
123
R00.2
ICD-10 Finland
Palpitations
2.3
6.2
55
252
F43.01
ICD-10 Finland
Acute stress reaction moderate
3.9
6.1
23
60
R44.3
ICD-10 Finland
Hallucinations, unspecified
12.7
6.1
10
8
K04.09
ICD-10 Finland
Pulpit UNS
2.7
6.1
39
148
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.1
6.1
68
342
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.8
6.1
97
563
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
4.4
6.1
20
46
J01DA01
ATC
[U] cefalexin; systemic
1.5
6.1
363
2963
TK800
NOMESCO Finland
Hemodialysis
8.7
6.1
12
14
S10
ICPC
Boil/carbuncle
2.7
6.1
39
149
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.5
6.1
46
194
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
10.1
6.0
11
11
IEV99
NOMESCO Finland
Other psychiatric network intervention
5.3
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
175
282
7.83
109.15
8.5
2.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
76
34
24.81
105.33
2.7
1.6
iu/ml
639865.6
974680.0
—
15
5
(3011288) Drugs identified in Urine by Screen method
213
459
6.12
99.16
13.0
2.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
198
499
5.06
75.57
9.0
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
207
586
4.52
67.69
8.8
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
214
625
4.42
67.12
8.8
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
213
623
4.40
66.63
9.0
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
213
626
4.38
66.16
9.2
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
252
918
3.65
56.59
2.8
1.6
%
1.6
1.4
5.41
216
833
(3032080) INR in Blood by Coagulation assay
321
1370
3.38
55.91
8.7
4.5
inr
1.1
1.1
1.03
153
489
(3009508) Creatinine [Moles/volume] in Urine
300
1266
3.31
52.63
7.1
3.0
mmol/l
7.3
8.3
2.40
261
1098
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
328
1465
3.23
52.20
3.5
2.2
u/l
49.7
54.7
2.31
296
1344
(3027944) Amphetamines [Presence] in Urine
191
621
3.80
50.23
8.3
1.6
—
—
—
0
0
(4198724)
52
48
11.58
49.12
5.7
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
423
2368
2.85
42.13
6.5
4.1
umol/l
10.5
10.1
0.13
380
2205
(3013826) Glucose [Moles/volume] in Serum or Plasma
477
2901
2.83
39.49
6.2
3.7
mmol/l
6.1
6.2
0.19
432
2514
(3025159) Blasts/100 leukocytes in Blood
123
355
3.96
37.71
3.6
4.3
%
0.0
0.0
0.49
24
70
(3017181) Myelocytes/100 leukocytes in Blood
128
384
3.82
37.11
3.5
4.2
%
0.6
0.8
0.43
26
87
(3021440) Promyelocytes/100 leukocytes in Blood
125
371
3.85
36.79
3.6
4.2
%
0.1
0.1
0.12
25
82
(40767503) Oxygen content in Capillary blood by calculation
48
61
8.35
35.73
2.7
1.9
%
16.8
16.8
0.01
23
31
(3002179) Metamyelocytes/100 leukocytes in Blood
118
350
3.82
34.67
3.4
4.0
%
0.7
0.5
0.21
21
61
(3013512) EKG study
225
991
2.83
34.20
4.1
2.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
212
944
2.75
31.19
6.3
3.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
308
1646
2.50
31.05
4.0
3.2
estimate
0.0
0.0
1.08
192
626
(3042517) Benzodiazepines panel - Urine
37
8
48.55
30.87
3.9
2.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
40
49
8.57
30.62
2.1
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
267
1358
2.51
29.69
4.6
2.5
ng/l
49.8
24.1
0.77
135
553
(3007463) Buprenorphine [Presence] in Urine
33
5
68.92
29.14
7.2
5.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
44
66
7.03
28.33
2.3
2.7
umol/l
29.7
33.6
0.48
37
57
(3027315) Oxygen [Partial pressure] in Blood
45
70
6.78
28.01
4.9
2.2
kpa
8.6
9.5
1.77
45
70
(3013290) Carbon dioxide [Partial pressure] in Blood
45
70
6.78
28.01
4.9
2.2
kpa
5.0
4.8
0.46
45
70
(3012501) Base excess in Blood by calculation
45
70
6.78
28.01
4.9
2.2
mmol/l
1.6
2.4
1.08
25
38
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
231
1127
2.53
27.78
2.8
2.0
u/l
242.3
227.6
0.06
217
1071
(3022806) Fractional oxyhemoglobin in Capillary blood
34
39
9.09
27.35
2.3
1.6
%
90.7
92.5
1.40
34
39
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
539
3831
2.51
27.16
8.9
5.1
u/l
76.0
71.3
2.05
496
3568
(3017143) Hepatitis C virus Ab [Presence] in Serum
238
1188
2.48
27.15
2.0
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
83
232
3.90
26.31
3.1
4.4
kpa
5.2
5.1
0.43
75
216
(3009343) pH of Capillary blood
83
232
3.90
26.31
3.0
4.4
ph
7.4
7.4
0.26
16
24
(3026008) Bacteria identified in Urine by Culture
297
1664
2.31
25.83
3.2
2.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
27
25
11.17
25.23
2.3
3.9
umol/l
94.4
191.0
0.79
14
14
(3021589) Normoblasts [#/volume] in Blood
406
2613
2.23
24.94
13.4
7.2
e9/l
0.0
0.0
0.46
368
2120
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
80
227
3.83
24.80
3.1
4.4
mmol/l
1.2
1.0
0.12
55
152
(3031040) Bacteria [#/volume] in Urine by Automated count
562
4153
2.49
24.63
5.3
3.8
e6/l
203.0
593.0
—
7
41
(1616796) Gas panel - Central venous blood
43
75
6.03
23.92
3.9
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
311
1823
2.22
23.79
7.3
4.3
mmol/l
1.2
1.2
4.06
283
1657
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
35
50
7.30
23.50
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
312
1843
2.20
23.30
3.8
2.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
65
167
4.17
23.07
1.7
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
107
386
3.07
22.69
4.3
2.3
—
—
—
0
0
(3026782) Osmolality of Urine
195
958
2.41
22.47
3.1
2.3
mosm/kgh2o
511.0
564.0
2.17
180
801
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
95
327
3.19
21.79
2.7
2.2
g/l
0.2
0.2
1.67
81
300
(3020191) Ethanol [Moles/volume] in Serum or Plasma
31
42
7.66
21.78
2.2
1.3
promille
1.7
1.2
0.70
26
31
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
331
2064
2.10
20.88
8.6
4.6
mmol/l
1.2
1.2
2.14
271
1735
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
181
887
2.38
20.79
2.6
2.3
u/l
13911.5
6888.3
1.22
72
365
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
363
2345
2.08
20.79
2.2
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
298
1789
2.12
20.77
5.3
3.6
g/l
35.3
37.1
5.70
270
1661
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
45
95
4.98
20.36
1.8
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
133
576
2.60
19.88
4.3
2.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
365
2393
2.04
19.76
4.2
3.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
325
2057
2.04
19.27
3.2
2.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
93
339
3.00
19.27
20.3
13.2
inr
1.2
1.1
0.19
11
55
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
73
231
3.40
19.14
11.0
7.9
mmol/l
24.2
24.5
0.29
73
231
(3037467) Urinalysis macro (dipstick) panel - Urine
556
4307
2.18
18.42
4.7
3.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
85
306
3.01
17.97
4.3
2.8
mmol/l
1.2
1.2
1.82
79
257
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
171
868
2.26
17.82
1.7
1.5
pmol/l
431.1
38370977.8
1.34
149
761
(3019309) Folate [Moles/volume] in Red Blood Cells
136
628
2.43
17.61
1.8
1.5
nmol/l
1285.6
1167.8
0.61
102
487
(3021901) Oxygen saturation in Capillary blood
31
53
6.06
17.57
3.0
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
139
651
2.40
17.43
3.9
2.7
ng/l
1346.4
912.5
0.64
112
491
(3013707) Erythrocyte sedimentation rate by Westergren method
531
4080
2.08
17.42
4.1
3.3
mm/h
11.5
8.6
4.26
484
3797
(3019225) pH of Specimen
91
349
2.83
17.14
2.8
2.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
465
5696
0.50
16.93
19.8
11.4
g/l
332.4
333.3
1.18
457
5651
(3042631) Mycobacterium sp identified in Specimen
21
24
8.98
16.84
3.3
3.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
297
1888
1.96
16.80
4.2
2.6
u/l
36.7
27.7
1.15
273
1804
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
132
618
2.38
16.51
2.2
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
537
4182
2.05
16.43
5.4
2.5
u/l
44.8
30.5
2.58
509
4005
(3012095) Magnesium [Moles/volume] in Serum or Plasma
127
588
2.40
16.27
4.1
2.5
mmol/l
0.8
0.8
0.46
115
542
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
22
9
25.13
16.08
1.1
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
41
98
4.37
15.95
3.7
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
127
603
2.34
15.32
2.2
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
402
2881
1.87
15.30
2.6
2.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
230
1381
1.97
15.05
2.3
2.0
mg/l
3.4
2.6
4.90
203
1175
(3000850) Epithelial cells [#/volume] in Urine
183
1017
2.06
14.86
2.8
2.2
e6/l
17.8
9.4
0.93
164
878
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
402
2902
1.85
14.73
4.4
3.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
176
968
2.07
14.67
1.5
1.4
nmol/l
18.9
21.0
1.11
154
854
(3002582) Erythrocytes [#/volume] in Urine
242
1490
1.93
14.63
3.5
2.6
e6/l
16.8
73.4
1.88
197
1095
(3022948) Iron [Moles/volume] in Serum or Plasma
133
671
2.20
13.79
2.5
1.9
umol/l
13.2
14.8
1.30
123
621
(3003396) Base excess in Arterial blood by calculation
78
310
2.70
13.67
10.6
7.1
mmol/l
0.8
0.7
0.11
65
233
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
331
2293
1.81
13.50
3.4
2.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
38
99
3.99
13.22
1.7
1.5
ug/l
0.9
3.4
0.43
32
86
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
261
1694
1.84
13.11
3.5
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
264
1723
1.83
13.00
1.9
1.7
pmol/l
97.4
96.6
0.10
151
953
(3035350) Ketones [Presence] in Urine by Test strip
413
3083
1.77
12.82
4.1
3.0
estimate
0.0
0.0
0.00
190
616
(3030467) Casts [#/volume] in Urine by Automated count
218
1354
1.87
12.51
3.3
2.6
e6/l
0.3
0.3
0.14
181
978
(3009261) Glucose [Presence] in Urine by Test strip
415
3119
1.76
12.42
4.3
3.1
estimate
0.0
0.0
0.00
197
619
(3022313) Gas panel - Capillary blood
50
164
3.20
12.35
2.9
5.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
57
4.88
12.21
5.0
4.1
u/ml
0.3
0.3
0.20
15
29
(3023511) Choriogonadotropin [Units/volume] in Urine
102
484
2.29
12.20
1.7
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
411
3091
1.75
12.18
5.3
4.2
estimate
0.0
0.0
0.50
197
636
(3007853) Bacteria identified in Skin by Aerobe culture
120
610
2.16
12.13
1.8
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
88
395
2.39
11.95
3.0
3.2
u/l
223.0
231.7
0.36
81
375
(3004789) Transferrin [Mass/volume] in Serum or Plasma
118
600
2.15
11.91
2.7
1.9
g/l
2.5
2.5
0.06
105
549
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
67
265
2.68
11.84
1.9
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
122
630
2.12
11.83
1.7
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
15
18
8.49
11.52
1.4
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
643
5587
2.18
11.51
19.4
8.3
mmol/l
3.9
3.9
1.89
615
5367
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
47
156
3.15
11.39
1.5
1.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
641
5573
2.15
11.29
19.2
8.3
mmol/l
139.2
139.4
1.86
614
5369
(3006184) Hemoglobin [Mass/volume] in Capillary blood
34
93
3.78
11.07
2.1
2.2
g/l
126.8
133.0
0.72
28
72
(3003458) Phosphate [Moles/volume] in Serum or Plasma
97
470
2.23
11.01
6.8
4.0
mmol/l
1.1
1.1
0.23
90
443
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
585
4945
1.89
10.93
4.6
4.0
pmol/l
14.5
14.3
0.89
531
4583
(3002032) Base excess in Venous blood by calculation
74
320
2.46
10.89
5.0
4.2
mmol/l
1.7
1.7
0.03
55
247
(3019832) Treponema pallidum Ab [Presence] in Serum
303
2142
1.70
10.84
2.0
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
257
1739
1.73
10.77
6.3
5.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
16
23
7.09
10.61
1.2
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
40
126
3.30
10.56
1.5
2.0
g/l
1.5
1.3
0.86
35
112
(3024354) Oxygen [Partial pressure] in Venous blood
67
283
2.50
10.36
5.2
4.0
kpa
5.2
4.7
0.95
60
274
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
25
57
4.50
10.33
2.7
2.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
362
2706
1.66
10.32
6.4
5.2
%
2.7
2.6
0.14
331
2525
(3019069) Monocytes/100 leukocytes in Blood
364
2727
1.66
10.28
6.7
5.4
%
7.8
7.8
0.07
335
2568
(3003694) ABO and Rh group [Type] in Blood
340
2508
1.66
10.16
2.0
1.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
73
324
2.39
10.15
5.2
4.1
kpa
6.0
5.8
1.17
67
315
(3014111) Lactate [Moles/volume] in Serum or Plasma
68
294
2.45
10.01
12.4
6.5
mmol/l
1.3
1.4
0.05
61
280
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
103
535
2.08
9.77
2.9
2.0
%
22.2
24.2
0.56
88
469
(3015377) Calcium [Moles/volume] in Serum or Plasma
222
1478
1.72
9.68
3.0
2.3
mmol/l
2.3
2.3
0.00
186
1314
(3036481) Cortisol [Moles/volume] in Serum or Plasma
104
546
2.05
9.58
1.6
1.8
nmol/l
357.7
388.1
1.00
96
504
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
91
458
2.13
9.36
3.5
2.9
%
32.5
32.0
0.16
65
332
(3022096) Basophils/100 leukocytes in Blood
346
2606
1.62
9.23
6.6
5.3
%
0.6
0.6
0.51
317
2431
(36304419) Bacteria [Presence] in Urine
207
1371
1.71
9.12
3.4
2.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
12
15
8.12
8.88
2.0
7.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
63
278
2.38
8.87
12.9
7.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
41
146
2.91
8.83
15.0
8.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
16
28
5.82
8.83
1.2
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
411
3265
1.59
8.50
10.3
7.4
e9/l
4.4
4.0
2.60
370
2853
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
190
1256
1.69
8.33
2.4
1.8
mg/l
1.1
0.9
0.47
141
923
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
50
204
2.56
8.33
2.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
597
5218
1.76
8.24
15.8
7.1
ml/min/173m2
99.6
97.5
1.42
522
4024
(3016650) Hepatitis A virus Ab [Presence] in Serum
34
114
3.08
8.14
1.1
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
365
2841
1.56
8.10
6.4
5.1
%
57.4
56.5
0.74
333
2675
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40
148
2.80
8.06
1.6
1.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
367
2869
1.56
7.93
6.6
5.2
%
28.5
29.8
1.37
334
2700
(3006315) Basophils [#/volume] in Blood
366
2873
1.54
7.68
6.7
5.4
e9/l
0.0
0.0
1.68
332
2530
(3033658) Prothrombin time (PT) actual/Normal
175
1158
1.67
7.56
5.6
3.0
%
91.3
96.0
1.39
164
1124
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
48
203
2.46
7.43
5.4
4.9
mmol/l
24.2
24.2
0.04
43
184
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
44
181
2.52
7.22
2.2
2.5
%
97.8
93.0
0.69
38
171
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
38
4.56
7.21
1.6
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
23
5.74
7.08
1.9
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
61
3.69
7.07
1.6
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
41
166
2.56
6.96
15.6
9.4
%
94.0
94.3
0.21
41
166
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
677
6230
2.06
6.90
12.5
7.0
u/l
26.2
24.0
1.74
652
6017
(3001604) Monocytes [#/volume] in Blood
361
2869
1.51
6.88
6.7
5.3
e9/l
0.6
0.5
4.73
329
2531
(3013115) Eosinophils [#/volume] in Blood
373
2986
1.50
6.85
7.2
5.7
e9/l
0.2
0.2
0.97
340
2685
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
94
3.06
6.72
2.5
3.3
e9/l
4.3
4.0
0.32
28
94
(3023419) Bacteria identified in Sputum by Culture
15
32
4.76
6.71
2.2
2.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
59
286
2.16
6.69
1.7
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
27
89
3.11
6.68
1.6
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
630
5682
1.75
6.66
5.6
4.6
mu/l
1.7
1.7
0.37
579
5371
(3018095) Leukocytes [#/volume] in Urine
263
1967
1.52
6.63
4.1
3.1
e6/l
42.8
66.7
0.87
207
1206
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
292
2234
1.51
6.61
2.5
2.2
nmol/l
72.4
72.0
0.08
268
2078
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
95
3.02
6.60
2.6
3.5
%
59.6
56.7
0.52
28
95
(3034274) Bile acid [Moles/volume] in Serum --fasting
59
288
2.14
6.57
1.8
2.3
umol/l
4.5
5.5
0.46
40
223
(3020682) Albumin/Creatinine [Ratio] in Urine
140
906
1.67
6.51
5.0
4.0
mg/mmol
17.2
12.1
0.29
98
619
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
55
3.71
6.51
1.2
1.1
ratio
1.0
1.1
0.17
11
24
(40768797) Stomach Pathology biopsy report
104
620
1.79
6.48
1.3
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
11
18
6.19
6.44
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
15
6.74
6.32
2.0
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
47
3.90
6.29
1.5
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
207
1484
1.55
6.28
4.9
3.8
—
—
—
0
0
(3015736) pH of Urine
306
2386
1.48
6.21
4.6
2.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
660
6065
1.84
6.12
18.6
8.8
mg/l
18.9
19.4
0.19
555
4585
(4035726)
56
277
2.11
6.04
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
240
1789
1.51
6.04
2.4
1.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
118
2.70
5.97
1.6
1.3
ug/g
276.1
321.0
0.36
14
52
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
16
6.32
5.97
2.0
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
54
3.59
5.91
1.8
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
36
4.23
5.84
1.9
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
34
749
0.43
5.79
1.4
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
419
3507
1.45
5.72
3.3
2.8
ug/l
67.2
60.1
0.66
379
3293
(3026493) Urate [Moles/volume] in Serum or Plasma
155
1062
1.58
5.68
2.8
2.1
umol/l
326.8
4580.5
3.03
137
955
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
15
37
4.12
5.65
2.1
1.5
pg
32.7
32.4
0.13
15
37
(3027945) Reticulocytes/100 erythrocytes in Blood
67
363
1.93
5.64
2.3
2.6
%
1.8
1.7
0.27
60
328
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
56
3.46
5.61
1.6
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
174
1233
1.54
5.48
4.6
2.7
ph
7.4
7.4
0.52
70
221
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
28
106
2.71
5.46
1.2
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
38
4.01
5.46
2.0
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
366
3005
1.43
5.43
7.2
5.4
e9/l
2.1
2.0
0.68
333
2718
(3023520) Reticulocytes [#/volume] in Blood
50
247
2.10
5.43
2.5
2.2
e9/l
78.5
73.3
0.50
37
173
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
74
420
1.85
5.41
2.4
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
35
149
2.42
5.40
1.8
4.5
g/l
0.2
0.2
0.22
13
65
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
18
5.62
5.33
2.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
29
656
0.42
5.28
1.5
1.5
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
16
44
3.69
5.23
1.5
1.6
mmol/l
1.9
1.7
0.62
16
44
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
14
35
4.06
5.19
1.1
1.1
iu/ml
252.9
185.9
0.41
14
35
(21494755) Public health laboratory ask at order entry panel
52
945
0.52
5.14
1.1
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
71
405
1.83
5.12
2.5
2.2
g/l
10.3
10.2
0.04
66
370
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
93
2.75
5.05
1.7
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
29
644
0.43
5.04
1.5
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
9
10.11
5.03
5.7
5.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
37
167
2.28
5.02
3.3
4.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
152
1069
1.53
4.91
1.2
1.2
iu/ml
15.0
25.9
2.15
35
298
(3012516) Albumin [Mass/volume] in Urine
128
866
1.58
4.91
3.9
3.2
mg/l
116.6
153.1
0.16
86
602
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
75
442
1.78
4.86
4.4
4.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
57
3.21
4.79
1.9
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
145
1015
1.53
4.78
1.2
1.2
u/ml
1.2
9.7
4.85
55
393
(3005033) Fetal Nuchal fold Thickness US
30
642
0.44
4.74
1.5
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
179
1312
1.48
4.74
2.3
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
92
579
1.67
4.72
1.4
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
18
58
3.16
4.66
1.4
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
576
5208
1.49
4.66
4.3
3.1
mmol/l
5.6
5.5
0.73
522
4837
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
70
410
1.78
4.64
2.4
1.6
—
—
—
0
0
(3036489) Thrombin time
43
214
2.07
4.61
2.3
2.2
s
24.7
20.5
0.64
32
184
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
39
187
2.15
4.60
1.9
2.2
ug/l
4.4
5.3
0.31
33
168
(3017569) Oxygen content in Arterial blood
9
11
8.27
4.57
2.3
9.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
11
8.27
4.57
4.2
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
184
1365
1.46
4.56
5.8
3.2
kg/l
1.0
1.0
0.44
36
201
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
8
10.09
4.53
1.4
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
686
6475
1.86
4.48
18.2
8.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
30
131
2.34
4.41
1.7
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
55
3.14
4.38
1.6
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
542
0.42
4.36
1.3
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
16
50
3.25
4.35
1.8
2.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
23
89
2.64
4.34
1.2
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
6
11.76
4.28
2.1
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
6
11.76
4.28
1.1
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
81
509
1.66
4.19
1.4
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
7
10.08
4.01
1.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
38
3.46
3.91
1.4
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
373
3183
1.35
3.90
3.8
2.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
27
121
2.28
3.78
3.4
2.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
8
8.82
3.78
1.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
7
8
8.82
3.78
2.1
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
12
6.73
3.68
1.5
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
73
2.65
3.66
2.3
4.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
29
136
2.18
3.66
1.2
1.3
titre
132.9
100.0
—
7
13
(4306422)
24
104
2.35
3.63
1.2
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
320
0.33
3.55
1.4
1.2
ug/l
2.2
3.6
1.11
11
304
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
26
3.89
3.53
1.3
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
10
26
3.89
3.53
1.2
1.7
u/field
2.4
7.7
—
5
20
(3000475) Leukocytes [#/volume] in Synovial fluid
18
69
2.65
3.49
1.9
1.9
e6/l
16164.6
13911.7
0.08
12
46
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
106
2.31
3.49
1.2
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
11
6.41
3.19
5.9
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
29
3.48
3.05
1.4
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
102
729
1.46
3.02
2.9
2.4
e6/l
4.0
3.9
0.04
63
381
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
21
4.33
3.00
2.7
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
21
4.33
3.00
4.6
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
51
2.78
3.00
2.1
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
86
595
1.50
2.99
1.6
1.6
mu/l
343.2
302.6
0.54
71
526
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
75
2.44
2.99
1.3
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
5
10.06
2.98
1.4
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
498
4525
1.31
2.94
5.3
3.7
mmol/mol
37.6
36.8
1.00
451
4288
(3021788) Differential panel - Synovial fluid
14
52
2.73
2.90
2.1
2.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
13
5.42
2.87
1.3
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
13
5.42
2.87
6.6
2.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
13
5.42
2.87
1.0
1.8
ug/l
11.3
7.5
—
7
13
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
13
5.42
2.87
6.6
2.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
9
6.71
2.87
1.0
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
9
6.71
2.87
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
9
6.71
2.87
1.0
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
31
166
1.91
2.80
2.8
2.6
%
204.3
162.6
1.37
31
161
(3002256) Pathology report gross observation
86
604
1.48
2.79
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
31
3.26
2.78
3.1
3.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
32
174
1.88
2.77
2.1
2.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
78
2.34
2.76
2.0
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
17
73
2.36
2.67
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
67
2.42
2.64
1.1
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
55
2.58
2.63
1.1
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
55
2.58
2.63
1.1
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
137
1058
1.36
2.62
1.7
2.2
—
—
—
0
0
(3000012) Reticulocyte production index
7
15
4.70
2.60
1.1
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
121
2.02
2.58
1.2
1.3
u/ml
3.8
6.1
—
9
45
(3037522) Nuclear Ab [Titer] in Serum
113
848
1.39
2.57
1.5
1.4
titre
240.0
535.6
4.35
26
162
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
16
68
2.38
2.57
1.1
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
169
1352
1.32
2.56
8.4
5.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
56
2.53
2.54
1.1
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
56
2.53
2.54
1.1
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
123
940
1.37
2.51
1.6
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
26
3.49
2.48
1.3
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
16
4.41
2.48
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
32
539
0.58
2.47
1.3
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
57
2.48
2.46
1.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
57
2.48
2.46
1.1
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
33
189
1.78
2.45
1.5
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
23
117
2.00
2.43
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
131
1018
1.35
2.41
2.2
2.3
ug/g
155.1
90.1
1.08
91
791
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
12
5.03
2.40
3.3
2.1
ug/l
56.7
135.2
—
6
12
(3007164) IgA [Mass/volume] in Serum or Plasma
189
1553
1.29
2.34
1.4
1.4
g/l
2.0
2.1
0.17
123
963
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
133
1.91
2.34
1.2
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
93
687
1.40
2.33
1.5
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
98
734
1.39
2.27
1.6
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
47
305
1.58
2.22
2.4
1.9
nmol/l
10.8
10.2
0.23
41
274
(40768446) Kidney Pathology biopsy report
5
9
5.58
2.21
3.4
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
13
54
2.43
2.20
3.2
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
42
2.64
2.19
1.2
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
101
2.01
2.17
1.4
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
14
4.31
2.15
1.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
14
4.31
2.15
1.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
14
4.31
2.15
1.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
14
4.31
2.15
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
37
2.73
2.11
1.4
6.1
—
—
—
0
0
(4024509)
11
43
2.58
2.10
1.7
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
31
2.93
2.07
1.9
3.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
54
368
1.50
2.07
1.4
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
56
2.35
2.05
1.2
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
16
76
2.13
2.03
1.3
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
37
232
1.63
2.03
4.6
3.8
ug/l
3.4
5.5
0.80
29
174
(3035941) MCH [Entitic mass]
711
6934
1.72
2.01
26.4
13.4
pg
29.8
29.9
0.43
702
6859
(3024731) MCV [Entitic volume]
711
6935
1.72
1.99
26.4
13.4
fl
89.6
89.5
0.33
702
6861
(3026361) Erythrocytes [#/volume] in Blood
711
6936
1.71
1.98
26.5
13.5
e12/l
4.4
4.5
5.69
701
6776
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
77
2.10
1.98
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
308
0.51
1.97
1.0
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
51
2.38
1.95
1.3
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
711
6938
1.70
1.95
26.6
13.5
e9/l
7.5
6.8
11.54
701
6770
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
94
718
1.35
1.95
3.1
2.5
ng/l
85.9
233.0
1.11
50
362
(3012441) Differential panel - Pleural fluid
5
11
4.57
1.94
1.2
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
16
3.77
1.94
2.5
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
39
2.59
1.92
1.2
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
10
39
2.59
1.92
1.3
1.4
—
60.0
—
0
5
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
39
2.59
1.92
1.2
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
76
562
1.39
1.92
3.6
2.1
umol/l
6.2
6.8
0.20
57
458
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
78
2.07
1.92
1.4
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
78
2.07
1.92
1.4
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
711
6941
1.69
1.90
26.8
13.6
g/l
131.5
134.4
7.40
701
6865
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
72
2.11
1.87
1.1
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
25
144
1.76
1.87
1.6
1.6
e6/l
35.8
129.7
0.90
19
120
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
25
144
1.76
1.87
1.6
1.5
e6/l
9.4
25.7
0.51
17
115
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
34
2.67
1.87
1.3
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
6
17
3.55
1.84
5.8
1.2
mg/l
58.0
66.6
—
6
11
(3025941) Bacteria identified in Stool by Culture
55
387
1.46
1.83
1.3
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
192
1.64
1.80
1.3
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
23
3.06
1.80
1.0
1.0
—
—
—
0
0
(3020891) Body temperature
20
109
1.86
1.78
5.1
4.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
709
6926
1.62
1.76
26.7
13.5
e9/l
270.1
262.8
1.98
697
6767
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
16
81
2.00
1.75
1.3
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
28
171
1.66
1.73
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
141
1.73
1.70
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
42
2.40
1.68
2.4
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
25
2.82
1.65
1.9
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
25
2.82
1.65
1.0
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
25
2.82
1.65
1.0
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
25
2.82
1.65
1.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
76
1.99
1.65
1.2
2.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
105
1.83
1.64
2.1
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
212
1834
1.22
1.63
1.7
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
243
2131
1.21
1.63
2.1
1.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
70
2.02
1.60
2.1
1.5
—
—
—
0
0
(4146454)
6
20
3.02
1.58
1.7
2.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
36
240
1.53
1.58
3.7
2.8
ng/l
105.9
61.2
2.31
30
218
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
64
2.05
1.55
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
33
2.44
1.54
1.3
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
43
0.00
1.52
0.0
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
16
86
1.88
1.51
1.3
1.8
g/l
0.6
0.3
0.36
16
77
(3029396) Erythrocyte agglutination [Presence] in Blood
12
58
2.09
1.50
3.3
3.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
210
1830
1.21
1.49
1.4
1.3
u/ml
1.6
1.6
0.00
81
469
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
170
1451
1.22
1.49
1.5
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
132
1.69
1.47
1.4
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
10
45
2.24
1.47
1.0
1.1
u/l
1.1
1.1
—
5
22
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
87
1.86
1.46
1.1
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
363
0.62
1.45
2.1
2.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
16
3.14
1.44
1.2
2.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
16
3.14
1.44
1.6
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
23
362
0.62
1.44
1.3
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
31
206
1.53
1.40
1.6
1.7
mmol/l
6.8
7.2
0.41
22
124
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
67
1.96
1.39
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
23
2.62
1.37
1.8
3.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
23
2.62
1.37
1.3
2.3
umol/l
11.4
13.8
—
6
23
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
23
2.62
1.37
2.3
1.9
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
6
23
2.62
1.37
2.3
1.7
%
43.3
32.9
—
6
14
(3051651) Icteric interference index of Serum or Plasma
6
23
2.62
1.37
4.0
3.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
46
333
1.41
1.36
1.6
1.3
u/l
7.8
8.6
0.23
36
273
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
17
2.95
1.36
1.0
2.8
u/l
214.2
192.9
—
5
17
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
17
2.95
1.36
1.8
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
17
97
1.77
1.36
1.9
1.6
pmol/l
184.1
181.4
0.03
17
89
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
24
152
1.60
1.33
1.3
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
43
2.11
1.30
1.4
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
64
494
1.32
1.29
1.5
1.3
iu/l
17.6
17.0
0.06
50
411
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
18
2.79
1.28
1.2
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
57
433
1.34
1.28
3.5
3.3
pmol/l
4.5
4.6
0.15
52
386
(4094501)
14
77
1.83
1.26
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
115
1.67
1.26
1.2
1.3
u/ml
6.4
4.9
0.30
12
53
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
45
2.01
1.23
2.3
2.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
45
2.01
1.23
2.9
2.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
52
392
1.35
1.23
1.2
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
25
371
0.66
1.22
1.5
1.5
mg/l
5.0
3.4
0.50
20
246
(4062490)
11
56
1.98
1.22
1.4
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
49
2.06
1.22
1.2
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
19
2.64
1.22
1.2
2.3
ml
1368.0
1981.3
—
5
19
(3009542) Hematocrit [Volume Fraction] of Blood
588
6087
0.83
1.20
15.9
9.9
%
38.8
39.9
2.44
413
5113
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
22
142
1.57
1.15
1.7
1.6
—
173.3
—
0
6
(3003740) Influenza virus B Ag [Presence] in Specimen
8
154
0.51
1.15
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
154
0.51
1.15
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
80
1.76
1.13
1.1
1.1
—
—
—
0
0
(4010399)
39
285
1.39
1.13
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
37
268
1.40
1.13
1.6
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
40
2.01
1.12
1.0
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
533
5093
1.17
1.11
3.5
2.8
mmol/l
1.3
1.2
1.90
486
4822
(4281824)
7
31
2.27
1.10
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
110
1294
0.82
1.10
1.7
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
21
2.39
1.09
1.6
1.6
nmol/l
157.2
138.4
—
5
21
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
66
526
1.28
1.08
4.1
3.9
ug/l
1.6
1.8
0.22
59
472
(3011397) Hemoglobin [Presence] in Urine by Test strip
119
1385
0.83
1.06
4.1
3.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
98
1.65
1.04
4.9
3.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
51
396
1.31
1.02
3.2
2.3
e9/l
4.5
4.3
0.24
37
347
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
69
845
0.80
1.01
1.3
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
53
1.90
1.01
1.0
1.3
nmol/l
—
—
—
0
0
(4027681)
10
53
1.90
1.01
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
188
0.58
1.00
1.3
1.7
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
17
107
1.60
1.00
1.1
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
91
761
1.22
1.00
2.9
2.2
e6/l
1.6
1.6
0.01
53
409
(3048929) Epstein Barr virus Ab [Presence] in Serum
46
354
1.32
0.99
1.4
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
23
2.18
0.98
2.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
29
0.00
0.98
0.0
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
46
355
1.32
0.97
1.7
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
54
1.86
0.97
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
85
711
1.22
0.94
3.4
2.1
mmol/l
2.5
2.4
1.60
65
601
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
70
1.73
0.93
1.1
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
52
1.74
0.92
1.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
78
1.68
0.92
1.4
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
28
2.15
0.91
1.8
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
94
1.61
0.91
1.2
1.6
g/l
7.3
7.4
0.02
15
76
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
94
1.61
0.91
1.2
1.6
—
—
—
0
0
(4034850)
10
170
0.58
0.91
11.5
8.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
23
160
1.45
0.90
1.4
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
201
2213
0.87
0.89
2.5
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
43
334
1.31
0.88
3.5
3.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
186
1.41
0.88
2.7
2.2
—
—
—
0
0
(1002224) Polysomnography panel
17
252
0.67
0.87
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
30
2.01
0.87
2.5
8.8
%
11.2
11.7
—
6
30
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
145
1.46
0.85
1.5
1.2
u/ml
347.4
209.7
0.56
14
81
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
22
155
1.43
0.82
1.5
1.4
u/l
12.8
12.8
0.00
15
136
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
27
199
1.37
0.79
1.4
1.5
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
25
0.00
0.79
0.0
1.2
—
96.8
—
0
13
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
28
208
1.36
0.78
1.4
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
27
0.00
0.77
0.0
1.0
—
95.1
—
0
15
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
18
124
1.46
0.75
1.6
1.2
u/ml
85.2
106.1
—
5
23
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
53
1.71
0.75
1.0
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
12
75
1.61
0.75
1.1
1.1
%
107.4
92.5
1.02
12
70
(3008898) HLA-B27 [Presence]
45
362
1.26
0.73
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
38
1.85
0.73
1.0
1.1
miu/ml
2078.3
1384.6
—
7
38
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
15
100
1.51
0.73
1.2
1.1
iu/ml
1.2
20.7
—
5
31
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
25
2.01
0.72
2.8
1.2
umol/l
29.0
29.9
—
5
25
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
134
1196
1.15
0.72
1.5
1.5
mmol/l
1.5
1.3
0.47
104
1048
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
75
641
1.19
0.70
2.0
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
48
393
1.24
0.68
4.4
2.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
42
1.67
0.68
1.9
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
205
1.33
0.68
1.3
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
43
1.63
0.67
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
43
1.63
0.67
1.3
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
557
5410
1.12
0.66
4.0
3.2
mmol/l
2.7
2.8
2.31
503
5096
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
62
1.62
0.65
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
549
5338
1.11
0.60
3.8
3.0
mmol/l
1.4
1.5
4.61
497
5055
(21494815) CD4 cells/100 lymphocytes in Specimen
8
51
1.57
0.60
2.4
2.3
—
43.3
—
0
6
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
52
1.54
0.59
1.0
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
551
5361
1.11
0.59
3.8
3.0
mmol/l
4.5
4.7
3.74
500
5092
(44806118)
8
53
1.51
0.58
1.6
1.5
—
—
—
0
0
(44790048)
8
53
1.51
0.58
1.6
1.5
—
—
—
0
0
(44790047)
8
53
1.51
0.58
1.6
1.5
—
—
—
0
0
(44790049)
8
53
1.51
0.58
1.6
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
16
116
1.39
0.54
1.6
2.2
mg/l
9.1
9.1
0.01
16
111
(3003327) Ova and parasites identified in Stool by Light microscopy
22
283
0.77
0.54
1.6
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
61
1.48
0.54
1.1
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.8
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
44
521
0.83
0.53
1.0
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
41
1.47
0.50
1.5
2.1
mmol/l
5.0
5.5
—
6
34
(3041354) Potassium [Moles/volume] in Venous blood
6
41
1.47
0.50
4.3
2.3
mmol/l
4.1
4.0
—
6
41
(3035285) Chloride [Moles/volume] in Venous blood
6
41
1.47
0.50
4.3
2.3
mmol/l
104.7
106.5
—
6
41
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
45
1.56
0.49
1.3
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
7
48
1.46
0.47
1.7
1.3
mu/l
54.3
39.7
—
7
42
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
121
0.66
0.45
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
143
1541
0.91
0.44
2.0
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
56
1.43
0.42
1.9
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
196
1.23
0.39
3.8
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
106
1.33
0.39
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
37
1.35
0.37
1.2
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
233
2223
1.07
0.36
1.9
1.7
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
42
1.43
0.35
1.3
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
6
42
1.43
0.35
2.0
1.1
u/ml
—
0.2
—
0
9
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
6
42
1.43
0.35
1.3
1.3
pmol/l
346.5
387.8
—
6
31
(3037756) Immunofixation for Serum or Plasma
6
43
1.40
0.35
1.2
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
52
462
1.14
0.35
1.3
1.3
miu/ml
191.9
257.5
0.55
19
246
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
31
265
1.18
0.34
1.3
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
14
177
0.79
0.33
1.4
1.3
—
49.1
—
0
10
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
74
1.36
0.32
9.6
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
120
1.26
0.30
1.1
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
55
1.28
0.30
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
194
1.19
0.30
2.0
2.1
iu/l
3.8
5.1
0.59
15
76
(4268621)
11
85
1.30
0.28
2.2
2.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
572
5651
1.05
0.22
4.2
4.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
40
1.25
0.22
5.0
2.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
40
1.25
0.22
1.4
1.2
g/l
1.0
0.9
—
5
40
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
21
241
0.87
0.21
1.1
1.1
u/ml
11.1
0.8
—
8
94
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
12
0.00
0.21
0.0
4.2
—
1.4
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
13
0.00
0.21
0.0
4.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.8
1.3
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(44813793)
6
52
1.16
0.19
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
49
526
0.93
0.17
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
60
638
0.94
0.16
1.3
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
556
5522
1.03
0.10
22.0
11.0
%
13.7
13.3
6.49
543
5416
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
48
1.04
0.09
4.0
2.8
u/ml
13.8
15.6
—
5
48
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
55
1.09
0.09
1.0
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
206
0.92
0.08
1.1
1.1
u/ml
2.5
0.6
—
8
86
(40768793) Breast Pathology biopsy report
10
113
0.88
0.08
1.1
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
15
137
1.10
0.07
1.1
1.0
u/ml
6.7
2.4
—
6
70
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
29
305
0.95
0.06
2.4
2.6
ug/l
0.6
0.7
0.35
22
179
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
193
0.93
0.06
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
125
1227
1.02
0.06
1.8
1.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
76
779
0.97
0.06
1.4
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
119
1.09
0.06
1.4
1.3
—
1.4
—
0
10
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
76
778
0.97
0.05
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
53
546
0.97
0.05
1.5
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
14
151
0.93
0.05
2.4
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
43
417
1.03
0.04
3.6
3.7
%
25.7
22.1
0.36
14
172
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
14
131
1.07
0.03
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
76
773
0.98
0.03
1.4
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
300
1.03
0.03
1.6
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
181
1.05
0.03
1.0
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
32
310
1.03
0.03
2.3
2.0
ml/min/173m2
62.9
81.1
1.10
14
105
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
122
1.07
0.02
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
20
192
1.04
0.02
1.5
1.5
nmol/l
0.3
0.5
1.87
14
168
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
55
542
1.02
0.01
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
77
777
0.99
0.01
1.4
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
65
644
1.01
0.00
1.3
1.2
iu/ml
95.7
176.2
1.63
29
252
(42529406) Shigella sp [Presence] in Stool by Culture
19
185
1.03
0.00
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
204
0.98
0.00
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
21
214
0.98
0.00
1.0
1.1
u/ml
4.2
5.9
0.31
12
121
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
50
497
1.01
0.00
3.7
1.8
u/l
29.3
32.2
0.46
40
409
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
179
1.01
0.00
1.0
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
25
249
1.00
0.00
4.4
2.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.3
—
0
7
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
83
0.96
0.00
1.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
98
0.92
0.00
1.1
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
102.3
—
0
6
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.2
—
6.5
—
0
5
(3020393) Adenovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
82
0.98
0.00
1.6
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PERSONAL_HISTORY_CERTA_OTH_DISEA – Personal history of certain other diseases
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).